ACCESSION: MSBNK-SMB_Measured-HSA001P0214017
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 196
COMMENT: RAW_SPEC {'BLK01_4722': {'bp': 3181890.0, 'sum': 8952327.0}, '12_posi_5078': {'bp': 906604.0, 'sum': 3100249.0}, '16_posi_4930': {'bp': 957178.0, 'sum': 3173010.0}, '15_posi_5099': {'bp': 969994.0, 'sum': 3188967.0}, '4_posi_4888': {'bp': 1038571.0, 'sum': 3406910.0}, '8_posi_4931': {'bp': 1047257.0, 'sum': 3382786.0}, '4_posi_4802': {'bp': 1065977.0, 'sum': 3389950.0}, '14_posi_4929': {'bp': 1083942.0, 'sum': 3504068.0}, '3_posi_4971': {'bp': 1284977.0, 'sum': 3911609.0}, 'BLK02_4953': {'bp': 1312638.0, 'sum': 4237071.0}, '1_posi_4946': {'bp': 1316658.0, 'sum': 3961411.0}, 'ProcedureBlank_5096': {'bp': 1432519.0, 'sum': 4065043.0}, '19_posi_5437': {'bp': 1792554.0, 'sum': 4921501.0}, '7_posi_5394': {'bp': 1916600.0, 'sum': 5172953.0}, '9_posi_5331': {'bp': 1919015.0, 'sum': 5226044.0}, 'BLK01_4869': {'bp': 2984219.0, 'sum': 9414880.0}, '17_posi_5287': {'bp': 469542.0, 'sum': 1814199.0}, '4_posi_5206': {'bp': 492602.0, 'sum': 1873740.0}, '11_posi_5265': {'bp': 536639.0, 'sum': 2002189.0}, '1_posi_5181': {'bp': 637400.0, 'sum': 2286009.0}, '7_posi_4806': {'bp': 847914.0, 'sum': 2895830.0}, '18_posi_5140': {'bp': 884382.0, 'sum': 3025440.0}, '19_posi_5014': {'bp': 919581.0, 'sum': 3042804.0}, '17_posi_4951': {'bp': 975037.0, 'sum': 3272915.0}, '15_posi_4911': {'bp': 1008596.0, 'sum': 3434033.0}, '3_posi_5057': {'bp': 1045664.0, 'sum': 3369742.0}, '4_posi_4973': {'bp': 1231330.0, 'sum': 3784923.0}, '13_posi_4993': {'bp': 1314659.0, 'sum': 4019506.0}, '13_posi_5372': {'bp': 1593258.0, 'sum': 4321383.0}, '17_posi_5417': {'bp': 1751399.0, 'sum': 4773742.0}, '15_posi_5438': {'bp': 2007139.0, 'sum': 5316051.0}, '14_posi_5350': {'bp': 2021440.0, 'sum': 5320383.0}, '9_posi_5417': {'bp': 2027798.0, 'sum': 5380947.0}, '8_posi_5097': {'bp': 504468.0, 'sum': 2052998.0}, '6_posi_5159': {'bp': 525341.0, 'sum': 1976834.0}, '9_posi_5097': {'bp': 643697.0, 'sum': 2459806.0}, '10_posi_5097': {'bp': 826995.0, 'sum': 2981936.0}, '4_posi_5288': {'bp': 935247.0, 'sum': 3182505.0}, '11_posi_4824': {'bp': 990759.0, 'sum': 3167473.0}, '13_posi_4912': {'bp': 992201.0, 'sum': 3314300.0}, '18_posi_4889': {'bp': 997911.0, 'sum': 3324835.0}, 'BLK02_4868': {'bp': 1094404.0, 'sum': 3742104.0}, '10_posi_4913': {'bp': 1192685.0, 'sum': 3727122.0}, 'ProcedureBlank_4930': {'bp': 1193524.0, 'sum': 3636167.0}, '13_posi_5078': {'bp': 1228142.0, 'sum': 3701804.0}, '2_posi_5055': {'bp': 1293967.0, 'sum': 3851293.0}, 'ProcedureBlank_5013': {'bp': 1337180.0, 'sum': 4020849.0}, '12_posi_5330': {'bp': 1599951.0, 'sum': 4370484.0}, 'ProcedureBlank_5182': {'bp': 1875811.0, 'sum': 5035752.0}, '4_posi_5373': {'bp': 1925814.0, 'sum': 5077078.0}, 'BLK01_5144': {'bp': 2804085.0, 'sum': 9102014.0}, '15_posi_5269': {'bp': 535028.0, 'sum': 1964159.0}, '5_posi_4325': {'bp': 547089.0, 'sum': 2037146.0}, '13_posi_5160': {'bp': 573095.0, 'sum': 2275267.0}, '11_posi_4346': {'bp': 629251.0, 'sum': 2385948.0}, 'BLK02_4219': {'bp': 634755.0, 'sum': 2487518.0}, '4_posi_4366': {'bp': 738545.0, 'sum': 2831649.0}, '13_posi_4829': {'bp': 943083.0, 'sum': 3016180.0}, '4_posi_5055': {'bp': 967186.0, 'sum': 3130499.0}, '2_posi_4807': {'bp': 995905.0, 'sum': 3242998.0}, '8_posi_5011': {'bp': 1127084.0, 'sum': 3459532.0}, '15_posi_5351': {'bp': 1862052.0, 'sum': 5194397.0}, '3_posi_5393': {'bp': 1868698.0, 'sum': 5065335.0}, '14_posi_5458': {'bp': 1932566.0, 'sum': 5132086.0}, '2_posi_5353': {'bp': 2146000.0, 'sum': 5808947.0}, 'BLK01_4154': {'bp': 2168621.0, 'sum': 7716667.0}, 'BLK01_4386': {'bp': 2306017.0, 'sum': 7857445.0}, '3_posi_5227': {'bp': 523645.0, 'sum': 1994948.0}, '8_posi_5182': {'bp': 535631.0, 'sum': 2117977.0}, '12_posi_5158': {'bp': 550479.0, 'sum': 2133925.0}, 'ProcedureBlank_4176': {'bp': 580712.0, 'sum': 2374726.0}, 'BLK02_4132': {'bp': 612409.0, 'sum': 2355192.0}, '10_posi_5265': {'bp': 622713.0, 'sum': 2287510.0}, '2_posi_4387': {'bp': 831440.0, 'sum': 3103790.0}, '6_posi_5073': {'bp': 910443.0, 'sum': 3094599.0}, '3_posi_4808': {'bp': 983845.0, 'sum': 3254815.0}, '12_posi_4823': {'bp': 1011099.0, 'sum': 3259003.0}, '1_posi_4780': {'bp': 1015598.0, 'sum': 3347665.0}, '9_posi_4844': {'bp': 1026283.0, 'sum': 3439179.0}, '19_posi_4931': {'bp': 1086171.0, 'sum': 3581678.0}, '11_posi_4913': {'bp': 1147884.0, 'sum': 3610193.0}, 'BLK02_5160': {'bp': 1605460.0, 'sum': 4542023.0}, '3_posi_5310': {'bp': 1736170.0, 'sum': 4818141.0}, 'BLK01_3988': {'bp': 1893194.0, 'sum': 6628952.0}, '10_posi_5354': {'bp': 1895158.0, 'sum': 5181228.0}, 'BLK01_4070': {'bp': 2112186.0, 'sum': 7465663.0}, 'BLK01_4233': {'bp': 2172003.0, 'sum': 8234994.0}, 'BLK01_5353': {'bp': 2251190.0, 'sum': 7474111.0}, '18_posi_5307': {'bp': 455080.0, 'sum': 1775793.0}, '14_posi_4363': {'bp': 693410.0, 'sum': 2612981.0}, '7_posi_4679': {'bp': 703849.0, 'sum': 2748897.0}, '17_posi_5035': {'bp': 964450.0, 'sum': 3084493.0}, '19_posi_5099': {'bp': 1040833.0, 'sum': 3336555.0}, '7_posi_5057': {'bp': 1210586.0, 'sum': 3594350.0}, '10_posi_4829': {'bp': 1225616.0, 'sum': 3999694.0}, '11_posi_5374': {'bp': 1690212.0, 'sum': 4641851.0}, '8_posi_5413': {'bp': 1714212.0, 'sum': 4620722.0}, '10_posi_5435': {'bp': 1863596.0, 'sum': 4909702.0}, '6_posi_5332': {'bp': 1951222.0, 'sum': 5270048.0}, 'BLK01_4633': {'bp': 2864553.0, 'sum': 9681805.0}, '6_posi_4346': {'bp': 577134.0, 'sum': 2166622.0}, '3_posi_4340': {'bp': 607525.0, 'sum': 2211236.0}, '1_posi_4283': {'bp': 661570.0, 'sum': 2469579.0}, '8_posi_4637': {'bp': 754059.0, 'sum': 2789967.0}, 'ProcedureBlank_4681': {'bp': 883829.0, 'sum': 3187972.0}, '8_posi_4842': {'bp': 990198.0, 'sum': 3245364.0}, '17_posi_4866': {'bp': 1006138.0, 'sum': 3259028.0}, 'ProcedureBlank_4844': {'bp': 1025202.0, 'sum': 3461524.0}, 'ProcedureBlank_4778': {'bp': 1074291.0, 'sum': 3829580.0}, '3_posi_4887': {'bp': 1087540.0, 'sum': 3589877.0}, '12_posi_4991': {'bp': 1322502.0, 'sum': 4046403.0}, '11_posi_4997': {'bp': 1361139.0, 'sum': 4171593.0}, '16_posi_5182': {'bp': 427006.0, 'sum': 1717991.0}, '8_posi_4324': {'bp': 479370.0, 'sum': 1843999.0}, '13_posi_4342': {'bp': 518372.0, 'sum': 2004234.0}, '13_posi_5244': {'bp': 550117.0, 'sum': 2087224.0}, '17_posi_4386': {'bp': 553214.0, 'sum': 2132073.0}, '16_posi_5270': {'bp': 572592.0, 'sum': 2144994.0}, '10_posi_5181': {'bp': 588908.0, 'sum': 2195825.0}, '11_posi_5183': {'bp': 598583.0, 'sum': 2271225.0}, '5_posi_4637': {'bp': 760629.0, 'sum': 2638359.0}, '15_posi_4829': {'bp': 903512.0, 'sum': 2938812.0}, '16_posi_4848': {'bp': 994771.0, 'sum': 3198481.0}, '10_posi_5011': {'bp': 1141389.0, 'sum': 3521777.0}, '15_posi_5012': {'bp': 1244810.0, 'sum': 3770102.0}, '6_posi_5437': {'bp': 1827032.0, 'sum': 4980099.0}, 'BLK01_4316': {'bp': 2251730.0, 'sum': 8175971.0}, 'BLK01_4552': {'bp': 2952870.0, 'sum': 10760508.0}, '17_posi_5116': {'bp': 499872.0, 'sum': 2011416.0}, '12_posi_4905': {'bp': 1134859.0, 'sum': 3748336.0}, '1_posi_5018': {'bp': 1444718.0, 'sum': 4206751.0}, '16_posi_5350': {'bp': 1597170.0, 'sum': 4524023.0}, '1_posi_5266': {'bp': 1661749.0, 'sum': 4563243.0}, '16_posi_5437': {'bp': 1852770.0, 'sum': 5083305.0}, 'BLK02_5395': {'bp': 1932645.0, 'sum': 5389381.0}, 'BLK01_4466': {'bp': 2451572.0, 'sum': 9189650.0}, '3_posi_5141': {'bp': 547579.0, 'sum': 2232476.0}, '16_posi_4366': {'bp': 557745.0, 'sum': 2076858.0}, '10_posi_4346': {'bp': 602124.0, 'sum': 2276842.0}, 'ProcedureBlank_4283': {'bp': 748049.0, 'sum': 2694549.0}, '2_posi_4618': {'bp': 889278.0, 'sum': 3456687.0}, '7_posi_4156': {'bp': 434221.0, 'sum': 1741298.0}, '10_posi_4682': {'bp': 768887.0, 'sum': 2565956.0}, '12_posi_4365': {'bp': 548816.0, 'sum': 2090106.0}, '12_posi_5412': {'bp': 1985377.0, 'sum': 5139672.0}, '16_posi_5012': {'bp': 1018716.0, 'sum': 3241263.0}, '11_posi_4659': {'bp': 649307.0, 'sum': 2462616.0}, '1_posi_4636': {'bp': 1010268.0, 'sum': 3467812.0}, '19_posi_5267': {'bp': 496335.0, 'sum': 1980080.0}, '8_posi_5332': {'bp': 1677885.0, 'sum': 4516927.0}, '2_posi_4970': {'bp': 1361032.0, 'sum': 4063748.0}, '5_posi_4905': {'bp': 1217947.0, 'sum': 3896538.0}, '14_posi_5015': {'bp': 1165568.0, 'sum': 3711643.0}, '1_posi_4863': {'bp': 1151141.0, 'sum': 3668614.0}, 'BLK02_4782': {'bp': 1068737.0, 'sum': 4193659.0}, '14_posi_4842': {'bp': 1012699.0, 'sum': 3285130.0}, '7_posi_5139': {'bp': 625425.0, 'sum': 2290049.0}, '7_posi_5224': {'bp': 572066.0, 'sum': 2207655.0}, '12_posi_5246': {'bp': 532064.0, 'sum': 2122736.0}, '8_posi_5261': {'bp': 506752.0, 'sum': 1939301.0}, '5_posi_5223': {'bp': 505912.0, 'sum': 2002767.0}, '19_posi_5351': {'bp': 439202.0, 'sum': 1726945.0}, '1_posi_5372': {'bp': 2066117.0, 'sum': 5532647.0}, 'BLK02_5247': {'bp': 1724178.0, 'sum': 4822626.0}, '2_posi_4891': {'bp': 1101447.0, 'sum': 3436070.0}, '7_posi_4886': {'bp': 1028090.0, 'sum': 3427591.0}, '6_posi_4908': {'bp': 976269.0, 'sum': 3178656.0}, '6_posi_4825': {'bp': 925253.0, 'sum': 3130117.0}, '18_posi_4970': {'bp': 924066.0, 'sum': 3130380.0}, '1_posi_5099': {'bp': 608678.0, 'sum': 2277923.0}, '15_posi_5182': {'bp': 560203.0, 'sum': 2265948.0}, '9_posi_5177': {'bp': 552907.0, 'sum': 2059373.0}, '14_posi_5181': {'bp': 503220.0, 'sum': 1865784.0}, '17_posi_5205': {'bp': 494506.0, 'sum': 1917225.0}, '7_posi_5312': {'bp': 1967278.0, 'sum': 5216502.0}, '18_posi_5394': {'bp': 1860787.0, 'sum': 5210115.0}, '5_posi_5307': {'bp': 1115500.0, 'sum': 3514654.0}, '7_posi_4972': {'bp': 1073743.0, 'sum': 3300745.0}, '5_posi_4826': {'bp': 1049856.0, 'sum': 3436987.0}, '11_posi_5096': {'bp': 760144.0, 'sum': 2732502.0}, '4_posi_5135': {'bp': 569808.0, 'sum': 2160828.0}, 'ProcedureBlank_5396': {'bp': 1905669.0, 'sum': 5040049.0}, 'BLK02_5078': {'bp': 1524638.0, 'sum': 4570768.0}, '18_posi_5055': {'bp': 1140553.0, 'sum': 3467234.0}, '9_posi_5249': {'bp': 499864.0, 'sum': 1918237.0}, '14_posi_5262': {'bp': 471898.0, 'sum': 1867332.0}, '9_posi_4932': {'bp': 1167982.0, 'sum': 3770478.0}, '5_posi_4987': {'bp': 1032343.0, 'sum': 3361121.0}, '2_posi_5139': {'bp': 650271.0, 'sum': 2641927.0}, '5_posi_5139': {'bp': 589500.0, 'sum': 2300112.0}, 'ProcedureBlank_5289': {'bp': 1959728.0, 'sum': 5191879.0}, '5_posi_5393': {'bp': 1851273.0, 'sum': 5005426.0}, '6_posi_4996': {'bp': 1254807.0, 'sum': 3804585.0}, '9_posi_5010': {'bp': 1070829.0, 'sum': 3365329.0}, '18_posi_5225': {'bp': 512234.0, 'sum': 2030985.0}, '2_posi_5224': {'bp': 562366.0, 'sum': 2158905.0}}
COMMENT: RETENTION_TIME_STDEV 0.685
COMMENT: PRECURSOR_M/Z_RAW 214.154694
COMMENT: PRECURSOR_M/Z_STDEV 0.000062
COMMENT: PRECURSOR_IN_MS1 mz 214.155064; int 94.299; delta(ppm) 1.059703
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+NH4; mz 199.155417; int 39.304; cor 0.650
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.305; C10H19N3O2; [M+H]+; delta(ppm) 0.304953
COMMENT: PROPOSED_MF SevenGoldenRules 0.370; C9H15N3O; [M+CH3OH+H]+; delta(ppm) 0.369917
COMMENT: PROPOSED_MF MS-FINDER 3.300; C10H19N3O2; [M+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF MS-FINDER 2.955; C9H15N3O; [M+CH3OH+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS5_Sirius 57.989; C10H19N3O2; [M+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.695; C9H15N3O; [M+CH4O+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H19N3O2; [M+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H15N3O; [M+CH4O+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS6_Sirius 105.263; C10H19N3O2; [M+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS6_Sirius 105.263; C9H15N3O; [M+CH4O+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS6_Sirius 56.172; C4H14FN6O; [M+CH4O+H]+; delta(ppm) 1.236047
COMMENT: PROPOSED_MF SIRIUS6_Sirius 54.977; C6H16FN3O2; [M+CH4O+H]+; delta(ppm) -5.033515
COMMENT: PROPOSED_MF SIRIUS6_Sirius 47.929; C8H17N6O; [M+H]+; delta(ppm) 6.571727
COMMENT: PROPOSED_MF SIRIUS6_Sirius 47.929; C7H13N6; [M+CH4O+H]+; delta(ppm) 6.571727
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.736; C5H18N4OP; [M+CH4O+H]+; delta(ppm) -1.141262
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.114; C12H21O3; [M+H]+; delta(ppm) -5.967452
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.114; C11H17O2; [M+CH4O+H]+; delta(ppm) -5.967452
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.351; C3H16N7P; [M+CH4O+H]+; delta(ppm) 5.128349
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.669; C4H17N6S; [M+CH4O+H]+; delta(ppm) -9.169758
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H19N3O2; [M+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H15N3O; [M+CH4O+H]+; delta(ppm) 0.302098
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.382; ILBQBCDZPWYQPS-UHFFFAOYSA-N; [M+H]+; CC(C)=CCN(CCCC(O)=O)C(N)=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.328; JVPFKVWSCCAXMM-UHFFFAOYSA-N; [M+H]+; O=C1N(CCOC)CC2N1CCN(C)C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.300; AGVCUVJROUBIKP-HGXVMFPFNA-N; [M+H]+; CC(C)[C@@H](N)C(=O)N1CCC[C@H]1C(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.299; HPBNRIOWIXYZFK-UHFFFAOYSA-N; [M+H]+; NC(N)=NCC1COC2(CCCCC2)O1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.618; ILBQBCDZPWYQPS-UHFFFAOYSA-N; [M+H]+; UNPD35190
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.428; HPBNRIOWIXYZFK-UHFFFAOYSA-N; [M+H]+; Guanadrel Sulfate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.216; JVPFKVWSCCAXMM-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxyethyl)-7-methyl-octahydroimidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.150; AGVCUVJROUBIKP-HGXVMFPFNA-N; [M+H]+; UNPD165572
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.647; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.623; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.597; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.581; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+CH3OH+H]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.479; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ILBQBCDZPWYQPS-UHFFFAOYSA-N; [M+H]+; UNPD35190
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; JVPFKVWSCCAXMM-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxyethyl)-7-methyl-octahydroimidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.873; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.646; HPBNRIOWIXYZFK-UHFFFAOYSA-N; [M+H]+; Guanadrel Sulfate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.537; AGVCUVJROUBIKP-HGXVMFPFNA-N; [M+H]+; UNPD165572
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.525; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.459; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.320; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+CH3OH+H]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.596; HPBNRIOWIXYZFK-UHFFFAOYSA-N; [M+H]+; 2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.274; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.456; VYCNDBQWMCGZAA-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-amino-5-butyl-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.442; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(diethylamino)-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.429; LISKJKUMLVQGKE-UHFFFAOYSA-N; [M+H]+; 1-morpholin-4-yl-2-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.253; HSCWDVRVHYGIFA-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-amino-1-[2-(dimethylamino)ethyl]pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; XIUNZPPHCCROJV-UHFFFAOYSA-N; [M+H]+; 2-morpholin-4-yl-1-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; HPYAUWCUNUYIDG-UHFFFAOYSA-N; [M+H]+; 4-piperazin-1-ylpiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; CQTKVYHURMMRPR-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; VINYJNGGVYOFMO-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-[2-(dimethylamino)ethoxy]pyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; HGZOYFLXLKNJHY-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-[2-(2-oxopyrrolidin-1-yl)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; UIVPKOOMHSYUNJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-3-(piperidin-3-ylmethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; DWMYGDSJFUBVKQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; XPNWLCXGUBWJGX-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-methyl-5-(4-methylpiperidin-4-yl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; ALMLRHBBDXINTB-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-4-(piperazin-1-ylmethyl)-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.743; VPIPHCYJMTYWDB-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; GMHNKGPHJQRSMQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; YONREVWIEOKSMK-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(azepan-2-yl)-5-methyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; SFUBOCVBYZCIFG-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-2-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.727; GXYDRMDRTXLIHI-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-(aminomethyl)-3,4-diethyl-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.723; BIOMFDHHARGJFB-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(3-methyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.714; VBBBTQSQJTVDDF-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-methyl-5-(oxan-4-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.711; FNHCEZVALREEJW-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.710; IVCVUYGTIKYXFG-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-[4-(oxolan-3-yl)pyrazol-1-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.693; BDYRHACUFFMVPT-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-methyliminopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; ZCUQKBLYCPKOJS-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-carbamimidoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; XXIODYOSZOJCLL-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-ethyl-5-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; HHJDARBBDLVPJM-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-N-(2-methoxyethyl)-5-N-methylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.636; KIJUVFXYFIUKHM-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propyl-6,7-dihydro-4H-pyrano[3,4-d]imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.624; HCBVNRIFWSZMKU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(4-amino-4,5,6,7-tetrahydroindazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.621; MUWLMGYRXAWPAY-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(3-ethyl-1,2,4-oxadiazol-5-yl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.610; OOFRPEDNTOJVQY-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(3,5-dimethyl-1H-pyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.608; QSCAGDQZSRZPOH-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-N-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.601; UHKUQSBZFWWHQL-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(2-amino-3-methylbutanoyl)azetidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.582; KDHIXBKIBCKZQU-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(1-methylimidazol-2-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; DQENLXHRPLSILC-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-amino-5-pentyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; BZFBHNLGVKEULM-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methylimidazol-2-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.560; GZIQHUCQRGBGBE-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-[(4-aminopyridin-2-yl)amino]-2-methylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.559; FSYSYUOZJAUBEU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-methylpyrazol-3-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.553; VNTQVHBPLVELRW-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(4-ethyl-1H-pyrazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.551; RYNLBXYARMGYPC-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-amino-5-butyl-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.550; JTINBOGNUWUGGZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-ethyl-3-piperidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.549; RFHQJLOTULCXTL-IONNQARKSA-N; [M+CH3OH+H]+; [(2R,3S)-2-(2-methylpyrazol-3-yl)oxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.549; GQUXEPBUPCLZTC-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.538; IMEFHYRQGSBUQA-BDAKNGLRSA-N; [M+CH3OH+H]+; (2S,3R)-2-(1,5-dimethylpyrazol-4-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.530; WKTDGUSTKNDUEI-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-propan-2-yl-3-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.528; QZKNQIWHWNZUPG-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methyl-2-(1-methylpyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.524; VWQGOQSMLIKZKR-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(5-methyl-1,2,4-oxadiazol-3-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.517; QXNSDFXNTPPPMD-JGVFFNPUSA-N; [M+CH3OH+H]+; [(3S,4S)-4-(3-methylimidazol-4-yl)pyrrolidin-3-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.495; LUJBSCAJUSLCOU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methylpyrazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.494; UROOQQFWCQYSFT-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(3-methylimidazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.460; JRAVVMHGQVQNIQ-UHFFFAOYSA-N; [M+CH3OH+H]+; [2-(oxan-2-yl)pyrazol-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.457; DFXAYHVELVUPEU-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-3-(3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)propanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.451; FNUWNALPTXNSAZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-cyclopentyloxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.436; YPJOOPMYFLEHFQ-UHFFFAOYSA-N; [M+CH3OH+H]+; [2-(1-methylpyrazol-4-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.435; SGVSDXUFVJGQOJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-imidazol-2-yl(piperidin-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.421; KBRISCUGMBXEQV-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(1-methylpyrazol-4-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.386; HMELYHQGWKUPAH-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(2-methylpyrazol-3-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.853; LISKJKUMLVQGKE; [M+H]+; piperazinoacetic acid-morpholide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.420; JVPFKVWSCCAXMM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.648; RYNLBXYARMGYPC; [M+CH4O+H]+; 6-Amino-5-butyl-2-methyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.468; GQUXEPBUPCLZTC; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.044; AGVCUVJROUBIKP; [M+H]+; L-valyl-L-prolinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.236; GMHNKGPHJQRSMQ; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.773; ZIJBPFPFSGVPTO; [M+CH4O+H]+; 2-amino-6-(3-methylbutyl)-3H-pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.316; FNHCEZVALREEJW; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.917; BONXRRQYFQOESU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.709; OEDOITYEASREQH; [M+H]+; 4-Morpholin-4-ylpiperidine-4-amide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.357; DQENLXHRPLSILC; [M+CH4O+H]+; 6-Amino-5-pentyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.428; CQTKVYHURMMRPR; [M+CH4O+H]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.339; NQCPECCCWDWTJJ; [M+CH4O+H]+; 2-(diethylamino)-6-methylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.719; MGESDKOHGQHZFN; [M+CH4O+H]+; Oprea1_123356
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.487; ILBQBCDZPWYQPS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -329.375; ZNXAJGZPUQOEDZ; [M+CH4O+H]+; Azepexol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -428.955; HPBNRIOWIXYZFK; [M+H]+; Hylorel
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.111; LISKJKUMLVQGKE; [M+H]+; piperazinoacetic acid-morpholide
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.022; RYNLBXYARMGYPC; [M+CH4O+H]+; 6-Amino-5-butyl-2-methyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.427; LISKJKUMLVQGKE; [M+H]+; 1-(Morpholinocarbonylmethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.994; NQCPECCCWDWTJJ; [M+CH4O+H]+; 2-(Diethylamino)-6-methyl-1H-pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.735; JVPFKVWSCCAXMM; [M+H]+; 2-(2-methoxyethyl)-7-methyl-octahydroimidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.907; ZIJBPFPFSGVPTO; [M+CH4O+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.641; VYCNDBQWMCGZAA; [M+CH4O+H]+; 2-Amino-5-butyl-6-methylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -224.445; MUWLMGYRXAWPAY; [M+CH4O+H]+; 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)cyclopentanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -244.645; RYNLBXYARMGYPC; [M+CH4O+H]+; 4-Pyrimidinol, 6-amino-5-butyl-2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -245.731; GQUXEPBUPCLZTC; [M+CH4O+H]+; 1-(2-methoxyethyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -252.614; ZNXAJGZPUQOEDZ; [M+CH4O+H]+; Azepexole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -255.136; BONXRRQYFQOESU; [M+H]+; 4-[[N'-(3-methylbut-2-enyl)carbamimidoyl]amino]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -260.900; ILBQBCDZPWYQPS; [M+H]+; 4-[N-(3-methylbut-2-en-1-yl)carbamimidamido]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -274.304; UHKUQSBZFWWHQL; [M+CH4O+H]+; 1-[(2S)-2-amino-3-methylbutanoyl]azetidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -290.595; JUSNBVJTFYDFKR; [M+H]+; (2S)-2-amino-5-(1-aminopent-3-enylideneamino)pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -291.171; PGZWFWGPWUBXAZ; [M+CH4O+H]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -292.595; HHJDARBBDLVPJM; [M+CH4O+H]+; N5-(2-methoxyethyl)-N5-methylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -297.932; VIABFASHQHHYNB; [M+H]+; 2-(Hydroxyimino)-N-(2-(azepan-1-yl)ethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -305.446; CIYWWIHMEYBDFA; [M+H]+; N5-(1-iminopent-3-enyl)-L-ornithine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -338.472; OEDOITYEASREQH; [M+H]+; 4-Morpholin-4-ium-4-ylpiperidin-1-ium-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -411.444; HPBNRIOWIXYZFK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -416.103; AGVCUVJROUBIKP; [M+H]+; 1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.385; LISKJKUMLVQGKE; [M+H]+; 1-(Morpholinocarbonylmethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.130; NQCPECCCWDWTJJ; [M+CH4O+H]+; 2-(Diethylamino)-6-methyl-1H-pyrimidin-4-one
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C10H20N3O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 9.968
MS$FOCUSED_ION: PRECURSOR_M/Z 214.155068
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-0790000000-4f387b38be5d46dac067
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495383 5.2271 56.050170 1.6236 2.01 0.5078 148 f{C3H6N1}/1.12ppm,p-C7H14N2O2
  68.0494090 8.3459 68.050040 1.4842 2.48 0.5750 184 f{C4H6N1}/-0.98ppm,p-C6H14N2O2
  83.0603363 44.6420 83.060840 0.7826 9.27 0.7128 196 f{C4H7N2}/-0.46ppm,p-C6H13N1O2
  85.0760108 48.2482 85.076490 0.6582 13.30 0.7914 196 f{C4H9N2}/-0.16ppm,p-C6H11N1O2
  86.0599733 9.7586 86.060440 1.4525 4.47 0.3410 194 f{C4H8N1O1}/-0.78ppm,p-C6H12N2O1
  87.0916869 56.7222 87.092140 0.5741 8.06 0.6869 196 f{C4H11N2}/0.14ppm,p-C6H9N1O2
  97.0760750 11.0027 97.076420 1.6482 3.91 0.6699 195 f{C5H9N2}/0.52ppm,p-C5H11N1O2
  111.0916844 321.2262 111.091900 0.2520 57.28 0.6603 196 f{C6H11N2}/0.09ppm,p-C4H9N1O2
  112.0756652 7.3632 112.075870 2.1236 2.97 0.4519 164 f{C6H10N1O1}/-0.22ppm,p-C4H10N2O1
  113.1073268 125.8301 113.107520 0.4067 10.27 0.7073 196 f{C6H13N2}/0.02ppm,p-C4H7N1O2
  126.1026232 46.9356 126.102650 0.8723 15.92 0.7296 196 f{C6H12N3}/0.39ppm,p-C4H8O2
  127.1104278 30.0751 127.110440 1.3296 10.34 0.7384 196 f{C6H13N3}/0.23ppm,p-C4H7O2
  128.1182725 91.3964 128.118270 0.6010 7.33 0.6948 196 f{C6H14N3}/0.38ppm,p-C4H6O2
  130.0863020 70.1549 130.086270 0.7533 22.94 0.7293 196 f{C6H12N1O2}/0.36ppm,p-C4H8N2
  130.1339128 391.1143 130.133880 0.2766 76.71 0.7104 196 f{C6H16N3}/0.30ppm,p-C4H4O2
  140.1183158 8.1429 140.118220 1.9484 3.31 0.5946 180 f{C7H14N3}/0.66ppm,p-C3H6O2
  141.0004463 25.3130 141.000350 1.3901 12.84 0.0347 196 ?
  154.1339348 28.8094 154.133830 1.3235 8.56 0.7282 196 f{C8H16N3}/0.39ppm,p-C2H4O2
  158.0270373 32.8595 158.026930 1.2023 16.88 -0.0926 196 ?
  169.0971344 48.3414 169.097020 0.8693 17.00 0.7741 196 f{C8H13N2O2}/-0.12ppm,p-C2H7N1
  170.1051551 14.0110 170.105040 1.6872 5.58 0.6130 196 f{C8H14N2O2}/1.03ppm,p-C2H6N1
  170.1652651 21.0055 170.165150 1.7160 7.20 0.6689 196 f{C9H20N3}/0.54ppm,p-C1O2
  171.1129657 8.0257 171.112850 2.6415 4.68 0.3830 153 f{C8H15N2O2}/0.94ppm,p-C2H5N1
  196.1638615 14.0356 196.163730 2.3807 5.94 0.4895 193 ?
  197.1286921 11.1180 197.128560 2.0646 4.66 0.5188 189 f{C10H17N2O2}/1.21ppm,p-H3N1
  197.1761321 98.5355 197.176000 0.6897 16.61 0.6235 196 ?
  214.1203926 30.3611 214.120250 2.1156 14.26 0.3318 185 ?
  214.1553727 652.7293 214.155230 0.5884 214.48 1.0000 196 f{C10H20N3O2}/1.72ppm,p
  214.2025027 999.0000 214.202360 0.3501 5.00 0.7235 196 ?
PK$NUM_PEAK: 29
PK$PEAK: m/z int. rel.int.
  56.049538 5.23 5
  68.049409 8.35 8
  83.060336 44.64 44
  85.076011 48.25 48
  86.059973 9.76 9
  87.091687 56.72 56
  97.076075 11.00 11
  111.091684 321.23 321
  112.075665 7.36 7
  113.107327 125.83 125
  126.102623 46.94 46
  127.110428 30.08 30
  128.118273 91.40 91
  130.086302 70.15 70
  130.133913 391.11 391
  140.118316 8.14 8
  141.000446 25.31 25
  154.133935 28.81 28
  158.027037 32.86 32
  169.097134 48.34 48
  170.105155 14.01 14
  170.165265 21.01 21
  171.112966 8.03 8
  196.163861 14.04 14
  197.128692 11.12 11
  197.176132 98.54 98
  214.120393 30.36 30
  214.155373 652.73 652
  214.202503 999.00 999
//
